| Ticker | Name | Market Capsorted ascending | Revenues TTM | 1W Pct | 1M Pct | 1Y Pct | PE | PS | ROE | Rev 3Y Grw | Drawdowns | Industry | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BGNE | BeiGene Ltd | 392.6B | 5.7B | - | - | - | 765 | 68.41 | 10.78% | 268.60% | - | Biotechnology | |
| ALNY | Alnylam Pharmaceuticals Inc | 39.2B | 4.3B | 4.00% | -1.20% | -9.60% | 75.4 | 9.15 | 48.37% | 274.90% | -37.80% | Biotechnology | |
| ARWR | Arrowhead Pharmaceuticals Inc | 11.2B | 622.0M | -1.50% | 6.50% | 400.00% | -37.17 | 18.07 | -49.26% | 128.00% | -54.50% | Biotechnology | |
| BMRN | BioMarin Pharmaceutical Inc | 11.1B | 3.2B | 4.20% | 6.00% | 4.80% | 41.23 | 3.42 | 4.33% | 49.20% | -64.40% | Biotechnology | |
| ACLX | Arcellx, Inc. | 6.7B | 22.3M | - | 0.10% | 96.90% | -29.12 | 299 | -56.90% | - | -0.10% | Biotechnology | |
| CELC | Celcuity Inc | 4.7B | - | 9.50% | -30.30% | 693.20% | -24.37 | - | -360.37% | - | -3.90% | Biotechnology | |
| AKRO | Akero Therapeutics Inc | 4.4B | 43.4M | 0.40% | 0.90% | 83.70% | -14.96 | 100 | -30.58% | - | -5.10% | Biotechnology | |
| ACAD | ACADIA Pharmaceuticals Inc | 4.0B | 1.1B | 8.20% | 10.70% | 4.20% | 10.65 | 3.65 | 30.10% | 110.50% | -61.50% | Biotechnology | |
| BEAM | Beam Therapeutics Inc | 3.5B | 164.0M | 4.30% | 18.30% | 97.60% | -53.21 | 21.25 | -5.63% | 113.80% | -79.70% | Biotechnology | |
| ADPT | Adaptive Biotechnologies Corp | 3.1B | 295.4M | 15.30% | 39.30% | 81.60% | -62.3 | 10.48 | -22.96% | 60.30% | -79.10% | Biotechnology | |
| CLDX | Celldex Therapeutics Inc | 2.7B | 1.5M | 2.50% | 9.90% | 56.00% | -9.35 | 1,714 | -62.17% | -34.40% | -99.90% | Biotechnology | |
| BCRX | BioCryst Pharmaceuticals Inc | 2.5B | 885.7M | 11.70% | 20.60% | 0.70% | -5.55 | 2.87 | 82.69% | 205.80% | -73.00% | Biotechnology | |
| AUPH | Aurinia Pharmaceuticals Inc | 2.4B | 298.3M | 15.20% | 22.20% | 131.10% | 8.02 | 8.02 | 52.54% | 103.20% | -51.60% | Biotechnology | |
| AGLE | Aeglea BioTherapeutics Inc | 2.2B | 24.7M | - | - | - | -12.08 | 87.63 | -26.75% | 2023.70% | - | Biotechnology | |
| AGIO | Agios Pharmaceuticals Inc | 2.2B | 66.0M | 9.60% | 28.90% | 8.50% | -5.09 | 32.59 | -38.10% | 247.30% | -81.20% | Biotechnology | |
| ADMA | ADMA Biologics Inc | 2.0B | 509.9M | 3.40% | 5.70% | -51.20% | 12.21 | 3.96 | 42.36% | 180.30% | -54.00% | Biotechnology | |
| AMLX | Amylyx Pharmaceuticals, Inc. | 1.9B | 87.4M | 11.50% | 25.30% | 165.40% | -12.6 | 18.25 | -54.95% | - | -58.40% | Biotechnology | |
| ABCL | AbCellera Biologics Inc | 1.8B | 79.2M | 10.80% | 16.00% | 63.90% | -12.79 | 23.25 | -15.35% | -78.80% | -93.00% | Biotechnology | |
| CAPR | Capricor Therapeutics Inc | 1.7B | 17.0M | 5.60% | 2.20% | 218.90% | -14.91 | 100 | -41.12% | 207.40% | -98.90% | Biotechnology | |
| ANAB | AnaptysBio Inc | 1.7B | 232.4M | 2.80% | -2.20% | 275.40% | -63.41 | 7.31 | -210.14% | 2073.70% | -54.20% | Biotechnology | |
| CBIO | Catalyst Biosciences Inc | 1.7B | 117.0M | -4.80% | -16.40% | 15.10% | -458 | 14.37 | -3.62% | 11.40% | -99.00% | Biotechnology | |
| ABSI | Absci Corporation | 1.6B | 1.8M | 40.20% | 97.50% | 258.40% | -13.26 | 855 | -68.87% | -70.40% | -87.00% | Biotechnology | |
| ABIO | ARCA biopharma Inc | 1.1B | 1.9M | - | - | - | -9.38 | 564 | -23.89% | - | - | Biotechnology | |
| ATAI | ATA Inc-China | 1.1B | 308.0K | 2.50% | -3.50% | 97.60% | -7.06 | 3,536 | -96.52% | - | -76.80% | Biotechnology | |
| CGEM | Cullinan Management, Inc. | 1.1B | 18.9M | 22.20% | 27.50% | 125.00% | -4.9 | 53.33 | -60.36% | - | -75.20% | Biotechnology |